HbA1c Below 7.5%, More Deaths

Major Finding: Hemoglobin A1c values below 7.5% were associated with increased all-cause mortality and cardiovascular events.

Data Source: A general practice database analysis of 47,970 type 2 diabetes patients with recently intensified glucose-lowering therapy.

Disclosures: The study was funded by Eli Lilly & Co. The investigators disclosed ties to numerous manufacturers of diabetes treatments, including Eli Lilly. The editorial authors reported relationships with several other pharmaceutical companies.